Document:

Warrant dated August 25, 2006

 Exhibit 10.3 
 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
 PRESCIENT APPLIED INTELLIGENCE, INC. 
 WARRANT FOR THE PURCHASE OF 
 1,000,000 SHARES OF COMMON STOCK 
 August 25, 2006 
 FOR VALUE RECEIVED Prescient Applied Intelligence, Inc., a Delaware corporation (the
“Company”), with its principal office at 1247 Ward Avenue, Suite 200, West Chester, PA 19380, hereby certifies that TAK Investments, LLC (the “Holder”) is entitled, subject to the provisions of this Warrant, to purchase from the
Company, at any time after the date hereof and continuing until 5:00 EST on December 31, 2006 (the “Expiration Date”), up to the number of fully paid and non-assessable shares of the Company’s Common Stock, par value $.001 per
share (the “Common Stock”) set forth above, subject to adjustment as hereinafter provided. 
 The Holder may purchase such number
of shares of Common Stock at a purchase price per share of $0.0825 (the “Exercise Price”). The term “Common Stock” shall mean the aforementioned Common Stock of the Company, together with any other equity securities that may be
issued by the Company in addition thereto or in substitution therefor as provided herein. 
 The number of shares of Common Stock to be
received upon the exercise or exchange of this Warrant and the price to be paid for a share of Common Stock are subject to adjustment from time to time as hereinafter set forth. The shares of Common Stock deliverable upon such exercise or exchange,
as adjusted from time to time, are hereinafter sometimes referred to as “Warrant Shares.” 
  

 1 

 Section 1. Exercise of Warrant. This Warrant may be exercised in whole or in part on any
business day after the date hereof but on or before the Expiration Date by presentation and surrender hereof to the Company at its principal office at the address set forth in the initial paragraph hereof (or at such other address as the Company may
hereafter notify the Holder in writing) with the Purchase Form annexed hereto duly executed and accompanied by proper payment of the Exercise Price in lawful money of the United States of America in the form of a check, subject to collection, a wire
transfer or a combination of such methods for the number of Warrant Shares specified in the Purchase Form. If this Warrant should be exercised in part only, the Company shall, upon surrender of this Warrant, execute and deliver a new Warrant
evidencing the rights of the Holder thereof to purchase the balance of the Warrant Shares purchasable hereunder. Upon receipt by the Company of this Warrant and such Purchase Form, together with proper payment of the Exercise Price, at such office,
the Holder shall be deemed to be the holder of record of the Warrant Shares, notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing such Warrant Shares shall not then be actually delivered
to the Holder. Upon receipt of the required deliveries, the Company shall, as promptly as practicable and no later than three (3) business days after receipt of the Purchase Form, cause to be issued and delivered to the Holder, a certificate or
certificates representing shares of Common Stock equal in the aggregate to the number of shares of Common Stock specified in the Purchase Form. The Company shall pay any and all documentary stamp or similar issue or transfer taxes payable in respect
of the issue or delivery of the Warrant Shares. 
 Section 2. Reservation of Shares. The Company hereby agrees that at all times
there shall be reserved for issuance and delivery upon exercise or exchange of this Warrant all shares of its Common Stock or other shares of capital stock of the Company from time to time issuable upon exercise or exchange of this Warrant. All such
shares shall be duly authorized and, when issued upon the exercise or exchange of the Warrant in accordance with the terms hereof, shall be validly issued, fully paid and nonassessable, free and clear of all liens, security interests, charges and
other encumbrances or restrictions on sale (other than any restrictions on sale pursuant to applicable federal and state securities laws) and free and clear of all preemptive rights. 
 Section 3. Fractional Interest. The Company will not issue a fractional share of Common Stock upon exercise or exchange of this Warrant.
Instead, the Company will deliver its check for the current market value of the fractional share. The current market value of a fraction of a share is determined as follows: multiply the Market Price (as defined in Section 6 below) of a full
share by the fraction of a share and round the result to the nearest cent. 
 Section 4. Assignment or Loss of Warrant.

 (a) Except as provided in Section 8, and only upon the presentation to the Company of written instruction from a bona fide officer,
manager or director of the Holder, the Holder of this Warrant shall be entitled, without obtaining the consent of the Company, to assign its interest in this Warrant, or any of the Warrant Shares, in whole or in part, provided, however, that
the transferee, if not an affiliate of the Holder, prior to any such transfer, agrees in writing, in form and substance satisfactory to the Company, to be bound by the terms of this Warrant as if originally a party hereto and provides the Company
with an opinion of counsel in such form reasonably acceptable to the Company and its counsel, that such transfer would not be in violation of the Act or any applicable state securities or blue sky laws. Subject to the 
  

 2 

 provisions hereof and of Section 8, upon surrender of this Warrant to the Company or at the office of its stock
transfer agent or warrant agent, with the Assignment Form annexed hereto duly executed by a bona fide officer, manager or director of the Holder and funds sufficient to pay any transfer or other tax payable in respect thereof, the Company shall,
without charge, execute and deliver a new Warrant or Warrants in the name of the assignee or assignees named in such instrument of assignment and, if the Holder’s entire interest is not being assigned, in the name of the Holder, and this
Warrant shall promptly be canceled. 
 (b) Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Warrant, and (in the case of loss, theft, destruction or mutilation) of indemnification satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated, or confirmation of loss, in the case of loss
or theft, the Company shall promptly execute and deliver a new Warrant of like tenor and date. 
 Section 5. Rights of the
Holder. The Holder shall not, by virtue hereof, be entitled to any rights of a shareholder in the Company, either at law or equity, and the rights of the Holder are limited to those set forth in this Warrant. Nothing contained in this Warrant
shall be construed as conferring upon the Holder hereof the right to vote or to consent or to receive notice as a shareholder of the Company on any matters or with respect to any rights whatsoever as a shareholder of the Company. No dividends or
interest shall be payable or accrued in respect of this Warrant or the interest represented hereby or the Warrant Shares purchasable hereunder until, and only to the extent that, this Warrant shall have been exercised or exchanged in accordance with
its terms. 
 Section 6. Adjustment of Exercise Price and Number of Shares. In the event of an adjustment of exercise price or
number of shares, the Company shall be required to provide the Holder with notice of such adjustment. Such notice shall be in accordance with Section 10 hereof. The number and kind of securities purchasable upon the exercise or exchange of this
Warrant and the Exercise Price shall be subject to adjustment from time to time upon the occurrence of certain events, as follows: 
 (a)
Adjustment for Change in Capital Stock. If at any time after the date hereof (the “Issue Date”), the Company: 
  

	 	(i)	pays a dividend or makes a distribution on its Common Stock, in either case in shares of its Common Stock; 

  

	 	(ii)	subdivides its outstanding shares of Common Stock into a greater number of shares; 

  

	 	(iii)	combines its outstanding shares of Common Stock into a smaller number of shares; or 

  

	 	(iv)	makes a distribution on its Common Stock in shares of its capital stock other than Common Stock; 

 then the Exercise Price in effect immediately prior to such action shall be proportionately increased or decreased, as the case may be. 
  

 3 

 (b) If at any time after the Issue Date, the Common Stock issuable upon the exercise of the Warrant is
changed into the same or a different number of shares of any class or classes of stock, whether by recapitalization, reclassification, exchange, substitution or otherwise, and other than a capital reorganization, merger or consolidation (the
adjustment for which is provided for in Section 6(c)), in any such event the Holder shall have the right thereafter to exercise this Warrant for stock into the kind and amount of stock and other securities and property receivable in connection
with such recapitalization, reclassification or other change that it would have been entitled to receive had it exercised this Warrant immediately prior to such recapitalization, reclassification, exchange, substitution or other event, all subject
to further adjustments as provided herein or with respect to such other securities or property by the terms thereof (and the Exercise Price of this Warrant shall be correspondingly adjusted). 
 (c) If at any time after the Issue Date, the Common Stock is converted into other securities or property, whether pursuant to a capital reorganization,
merger, consolidation or otherwise (other than a recapitalization, reclassification, subdivision, exchange or substitution of shares provided for in Section 6(b)), as a part of such transaction, provision shall be made so that the Holder shall
thereafter be entitled to receive upon exercise of this Warrant the number of shares of stock or other securities or property to which a holder of the number of shares of Common Stock deliverable upon conversion would have been entitled to receive
in connection with such transaction, subject to adjustment in respect of such stock or securities by the terms thereof (and the Exercise Price of this Warrant shall be correspondingly adjusted). To the extent applicable, appropriate adjustment shall
be made in the application of the provisions of this Section 6 with respect to the rights of the Holder after such transaction to the end that the provisions of this Section 6 (including adjustment to the number of shares issuable upon
exercise of the Warrant and the adjustment of the Exercise Price thereof) shall be applicable after that event and be as nearly equivalent as practicable. 
 (d) In case the Company shall fix a payment date for the making of a distribution to all holders of Common Stock (including any such distribution made in connection with a consolidation or merger in which the Company
is the continuing corporation) of evidences of indebtedness or assets (other than cash dividends or cash distributions payable out of consolidated earnings or earned surplus or dividends or distributions referred to in Section 6(a)), or subscription
rights or warrants, the Exercise Price to be in effect after such payment date shall be determined by multiplying the Exercise Price in effect immediately prior to such payment date by a fraction, the numerator of which shall be the total number of
shares of Common Stock outstanding multiplied by the Market Price (as defined below) per share of Common Stock immediately prior to such payment date, less the fair market value (as determined by the Company’s Board of Directors in good faith)
of said assets or evidences of indebtedness so distributed, or of such subscription rights or warrants, and the denominator of which shall be the total number of shares of Common Stock outstanding multiplied by such Market Price per share of Common
Stock immediately prior to such payment date. 
 (e) An adjustment to the Exercise Price shall become effective immediately after the payment
date in the case of each dividend or distribution and immediately after the effective date of each other event which requires an adjustment. 
  

 4 

 (f) The Company shall give written notice to the Holder at least fifteen (15) days prior to the date
on which any merger or reclassification provided for in Section 6(c) hereof shall take place. 
 (g) Deferral of Issuance or
Payment. In any case in which an event covered by this Section 6 shall require that an adjustment in the Exercise Price be made effective as of a record date, the Company may elect to defer until the actual occurrence of such event
(i) issuing to the Holder, if this Warrant is exercised after such record date, the shares of Common Stock and other capital stock of the Company, if any, issuable upon such exercise over and above the shares of Common Stock or other capital
stock of the Company, if any, issuable upon such exercise on the basis of the Exercise Price in effect prior to such adjustment, and (ii) paying to the Holder by check any amount in lieu of the issuance of fractional shares pursuant to
Section 3. 
 (h) When No Adjustment Required. No adjustment need be made for a change in the par value of the Common Stock.

 (i) Market Price. The “Market Price” per share of Common Stock is the closing price of the Common Stock on the last trade
date prior to the date of exercise, as reported by the primary national securities exchange or other primary trading market on which the Common Stock is then quoted; provided, however, that if the Common Stock is not then publicly traded, the
Market Price shall be reasonably determined by the Company’s Board of Directors. The Company shall respond within three (3) business days, in writing, to an inquiry by the Holder prior to the exercise hereunder as to the Market
Price of a share of Common Stock as determined by the Company. 
 (j) No Adjustment Upon Exercise of Warrants. No adjustments shall be
made under any Section herein in connection with the issuance of Warrant Shares upon exercise or exchange of the Warrants. 
 (k) Common
Stock Defined. Whenever reference is made in this Section 6 to the issue of shares of Common Stock, the term “Common Stock” shall include any equity securities of any class of the Company hereinafter authorized which shall not be
limited to a fixed sum or percentage in respect of the right of the thereof to participate in dividends or distributions of assets upon the voluntary or involuntary liquidation, dissolution or winding up of the Company. Subject to the provisions of
Section 6(c) hereof, however, shares issuable upon exercise or exchange hereof shall include only shares of the class designated as Common Stock of the Company as of the date hereof or shares of any class or classes resulting from any
reclassification or reclassifications thereof or as a result of any corporate reorganization as provided for in Section 6(c) hereof. 
 Section 7. Officers’ Certificate. Whenever the Exercise Price shall be adjusted as required by the provisions of Section 6, within three (3) business days of any adjustment of the number of shares issuable upon
exercise hereof, the Company shall give written notice thereof to the Holder, setting forth in reasonable detail and certifying the calculation of such adjustment by providing an officers’ certificate showing the adjusted Exercise Price
determined as herein provided, setting forth in reasonable detail the facts requiring such adjustment and the manner of computing such adjustment. Each such officers’ certificate shall be signed by the chairman, president or chief financial
officer of the Company and by the secretary or any assistant secretary of the Company. 
  

 5 

 Section 8. Transfer to Comply with the Securities Act of 1933; Registration Rights. No
sale, transfer, assignment, hypothecation or other disposition of this Warrant or of the Warrant Shares shall be made unless any such transfer, assignment or other disposition will comply with the rules and statutes administered by the Securities
and Exchange Commission and (i) a registration statement under the Act including such Shares is currently in effect, or (ii) in the written opinion of counsel, which counsel and which opinion shall be reasonably satisfactory to the
Company, a current registration statement is not required for such disposition of the shares. Each stock certificate representing Warrant Shares issued upon exercise or exchange of this Warrant shall bear a legend in substantially the following form
(unless, in the opinion of counsel, which counsel and which opinion shall be reasonably satisfactory to the Company, such legend is not required): 
 “THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY
AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.” 
 Section 9. Modification and Waiver. Except as otherwise provided herein, any term of this Warrant may be amended, and the observance of any term of this Warrant may be waived (either generally or in a
particular instance, either retroactively or prospectively, and either for a specified period of time or indefinitely), with the written consent of the Company and the written consent of a bona fide officer or director of the Holder of this Warrant.
Any amendment or waiver effected in accordance with this section shall be binding upon each future Holder of this Warrant and the Company. 
 Section 10. Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be deemed effectively given upon personal delivery, or by facsimile (with proof of receipt), or on the first
business day following mailing by overnight courier, or on the fifth day following mailing by registered or certified mail, return receipt requested, postage prepaid, addressed to the Company at the address indicated therefor in the first paragraph
of this Warrant and the Holder at its address as shown on the books of the Company; provided, however, that presentation of a Purchase Form and payment of any Exercise Price shall be effective only upon receipt by the Company. 
 Section 11. Descriptive Headings and Governing Law. The titles of the paragraphs and subparagraphs of this Warrant are for convenience of
reference only and are not 
  

 6 

 to be considered in construing this Warrant. This Warrant shall be governed by and construed under the laws of the
Commonwealth of Pennsylvania without regard to any otherwise applicable principles of conflicts of laws. 
 Section 12. Entire
Agreement. This Warrant and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof and no party shall be liable or bound to any other party in
any manner by any representations, warranties, covenants or agreements except as specifically set forth herein or therein. Nothing in this Warrant, express or implied, is intended to confer upon any party, other than the parties hereto and their
respective successors and assigns, any rights, remedies, obligations, or liabilities under or by reason of this Warrant, except as expressly provided herein. 
 Section 14. Severability. In the event that any provision of this Warrant shall be invalid, illegal or unenforceable, it shall, to the extent practicable, be modified so as to make it valid, legal and
enforceable and to retain as nearly as practicable the intent of the parties, and the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. To the extent permitted by law, the
parties hereto waive the benefit of any provision of law that renders any provision of this Warrant invalid or unenforceable in any respect. 
 Section 15. No Waiver. No waiver by any party to this Warrant of any one or more defaults by any other party or parties in the performance of any of the provisions hereof shall operate or be construed as a waiver of any future
default or defaults, whether of a like or different nature. Except as expressly provided herein, no failure or delay on the part of any party in exercising any right, power or remedy hereunder shall operate as a waiver thereof, nor shall any single
or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power or remedy. 
 IN WITNESS WHEREOF, the Company has duly caused this Warrant to be signed by its duly authorized officer and to be dated as of this 25th day of August, 2006. 
  

			
	Prescient Applied Intelligence, Inc.
		
	By:	 	 /s/ Thomas W. Aiken

	Name:	 	Thomas W. Aiken
	Title:	 	SVP &CFO

  

 7 

 PURCHASE FORM 
 [INSERT DATE] 
 The undersigned hereby irrevocably elects to exercise the within Warrant to purchase
             shares of Common Stock and hereby makes payment of
                         in payment of the exercise price thereof. 
  

	
	_____________________________
	
	Signature of TAK Investments, LLC Officer or Director
	
	_____________________________
	
	 Print Name of TAK Investments, LLC Officer or Director

  

 8 

 ASSIGNMENT FORM 
 [INSERT DATE] 
 FOR VALUE RECEIVED,
             hereby sells, assigns and transfers unto
                                        
     (the “Assignee”), 
  

 [INSERT ADDRESS] 
 its right to purchase up to
             shares of Common Stock represented by this Warrant and does hereby irrevocably constitute and appoint
                             
 Attorney, 
 to transfer the same on the books of the Company, with full power of substitution in the premises. 

 

	
	_____________________________
	
	Signature of TAK Investments, LLC Officer or Director
	
	_____________________________
	
	 Print Name of TAK Investments, LLC Officer or Director

  

 9Form of Voting and Option Agreement

 Exhibit 10.1 
 VOTING AND OPTION AGREEMENT 
 VOTING AND OPTION AGREEMENT (this “Agreement”), dated
as of August     , 2006, by and among RF Monolithics, Inc., a Delaware corporation (“Parent”), CI Acquisition, Inc., a Georgia corporation and a wholly-owned subsidiary of Parent (“Merger
Subsidiary”), Cirronet Inc., a Georgia corporation (“Cirronet”), and the shareholders listed on Schedule I hereto (each, a “Shareholder”). Capitalized terms used herein but not otherwise defined herein
shall have the meanings ascribed to them in the Merger Agreement (as defined below). 
 W I T N E S S E T H: 
 WHEREAS, concurrently with the execution and delivery of this Agreement, an Agreement and Plan of Merger (as such agreement may be amended from time to
time, the “Merger Agreement”) has been entered into by and among Parent, Merger Subsidiary, Cirronet, Robert M. Gemmell and the Shareholders’ Representative identified therein, pursuant to which Parent has agreed to cause
Merger Subsidiary to merge with and into Cirronet, with Cirronet continuing as the surviving corporation (the “Merger”); and 
 WHEREAS, as a condition to, and in consideration for, Parent’s and Merger Subsidiary’s willingness to enter into the Merger Agreement and to consummate the transactions contemplated thereby, Parent and Merger Subsidiary have
required that each Shareholder enter into this Agreement. 
 NOW, THEREFORE, in consideration of the foregoing and the mutual
representations, warranties, covenants and agreements contained herein, the parties hereto, intending to be legally bound, hereby agree as follows: 
 Section 1. Definitions. For purposes of this Agreement: 
 “Agreement” shall have the meaning set forth
in the preamble to this Agreement. 
 “Alternate Proposals” shall have the meaning set forth in Section 2 hereof.

 “Cirronet” shall have the meaning set forth in the preamble to this Agreement. 
 “Cirronet Common Stock” means Cirronet’s common stock, par value $0.01 per share. 
 “Existing Securities” shall have the meaning set forth in Section 6(a)(i) hereof. 
 “Fully-Diluted Cirronet Common Stock” shall mean the aggregate number of shares of Cirronet Common Stock issued and outstanding at the
date hereof if all Cirronet Options (whether vested or unvested) were exercised into Cirronet Common Stock immediately prior to the date hereof, other than any Cancelled Shares. 
 “Merger” shall have the meaning set forth in the recitals to this Agreement. 
 “Merger Agreement” shall have the meaning set forth in the recitals to this Agreement. 

 “Merger Subsidiary” shall have the meaning set forth in the preamble to this Agreement.

 “Notice Date” shall have the meaning set forth in Section 4(b) hereof. 
 “Option” shall have the meaning set forth in Section 4(a) hereof. 
 “Option Closing” shall have the meaning set forth in Section 4(b) hereof. 
 “Option Expiration Date” shall have the meaning set forth in Section 4(a) hereof. 
 “Parent” shall have the meaning set forth in the preamble to this Agreement. 
 “Proxy” shall have the meaning set forth in Section 3(a) hereof. 
 “Purchase Price” shall have the meaning set forth in Section 4(a) hereof. 
 “Shareholder” shall have the meaning set forth in the preamble to this Agreement. 
 “Subject Shares” means (A) the Existing Securities set forth on Schedule I hereto, (B) any shares of Cirronet Common
Stock distributed prior to the termination of this Agreement in respect of the Subject Shares by reason of a stock dividend, split-up, recapitalization, reclassification, combination, merger, exchange of shares or otherwise and (C) any other
shares of Cirronet Common Stock of which the Shareholder acquires beneficial ownership after the date hereof and prior to the Effective Time. 
 “Voting Expiration Date” means the earlier to occur of (A) the termination of the Merger Agreement in accordance with the terms thereof or (B) the Effective Time. 
 All capitalized terms and words used herein and not otherwise defined herein shall have the meanings ascribed to them in the Merger Agreement.

 Section 2. Agreement to Vote Shares. Until the Voting Expiration Date, the Shareholder shall, at any meeting of the holders of
Cirronet Common Stock, however such meeting is called and regardless of whether such meeting is a special or annual meeting of shareholders of Cirronet, or at any adjournment or postponement thereof, or in connection with any written consent of
shareholders of Cirronet, vote, or cause to be voted, the Subject Shares: (A) in favor of the Merger and each of the other transactions contemplated by the Merger Agreement and this Agreement (and any actions required in furtherance thereof and
hereof) and (B) against the following actions (other than the Merger and the transactions contemplated by the Merger Agreement) (collectively, “Alternate Proposals”): (i) any Acquisition Proposal or (ii) any other
action that is intended, or could reasonably be expected, to materially impede, interfere with, delay, postpone, discourage or adversely affect the consummation of the Merger or the transactions contemplated by the Merger Agreement. 
  

 2 

 Section 3. Grant of Proxy; Revocation of Proxies; Reliance. 
 (a) The Shareholder hereby irrevocably grants to and appoints [David M. Kirk] and [James P. Farley] or either of them in their respective capacities as
officers of Merger Subsidiary, with full power of substitution (such individuals and their substitutes each being referred to herein as the “Proxy”), as attorneys and proxies to vote all Subject Shares or to express consent or
dissent to corporate action in writing without a meeting, all as the Shareholder is obligated to do pursuant to Section 2 hereof, in the Proxy’s absolute, sole and binding discretion. The Shareholder agrees that the Proxy may, in the
Shareholder’s name and stead, (i) attend any annual or special meeting of shareholders of Cirronet and vote all Subject Shares on all matters regarding the Merger and each of the other transactions contemplated by the Merger Agreement and
this Agreement (and any actions required in furtherance thereof and hereof) or any Alternate Proposal at any such annual or special meeting, and (ii) execute with respect to all Subject Shares any written consent to, or dissent from, corporate
action respecting any matter regarding the Merger and each of the other transactions contemplated by the Merger Agreement and this Agreement (and any actions required in furtherance thereof and hereof) or any Alternate Proposal to which the
shareholders of Cirronet are entitled to express such consent or dissent without a meeting, all to the same extent as the Shareholder is obligated to do pursuant to Section 2 hereof. Other than as contemplated by Section 2 hereof, with
respect to any matter regarding the Merger and each of the other transactions contemplated by the Merger Agreement and this Agreement (and any actions required in furtherance thereof and hereof) or any Alternate Proposal, the Shareholder agrees to
refrain from (A) voting at any annual or special meeting of shareholders of Cirronet, (B) executing any written consent in lieu of a meeting of shareholders of Cirronet, (C) exercising any rights of dissent with respect to the Subject
Shares, and (D) granting any proxy or authorization to any Person with respect to the voting of the Subject Shares, except pursuant to this Agreement, or taking any action contrary to or in any manner that violates the terms of this Agreement.
The Shareholder agrees that, prior to the Voting Expiration Date, this grant of proxy pursuant to this Section 3(a) is irrevocable and coupled with an interest and agrees that the Persons designated as the Proxy pursuant hereto may at any time
name any other person who is an officer of Merger Subsidiary as a substitute Proxy hereunder to act pursuant hereto, either as to a specific matter or as to all matters. Upon the occurrence of the Voting Expiration Date, this grant of proxy pursuant
to this Section 3(a) shall be automatically revoked and of no further effect. The Shareholder further agrees to execute all additional writings, consents and authorizations as may be reasonably requested by the Proxy to evidence the powers
granted to the Proxy hereby or to enable the Proxy to exercise those powers. 
 (b) The Shareholder hereby represents that any proxies
heretofore given in respect of the Subject Shares are not irrevocable, and that any such proxies are hereby revoked. 
 (c) The Shareholder
understands and acknowledges that Parent, Merger Subsidiary and Cirronet have entered into the Merger Agreement in reliance upon the Shareholder’s execution and delivery of this Agreement. The Shareholder hereby affirms that this Agreement is
given in connection with the execution of the Merger Agreement and agrees to the duties of the Shareholder under this Agreement. 
  

 3 

 Section 4. Grant of Option; Exercise; Closing. 
 (a) Each Shareholder hereby grants to Parent an irrevocable option (each, an “Option”) to purchase the Subject Shares at a price per
share equal to the quotient derived by dividing (i) the sum of $24,000,000 plus the Aggregate Option Exercise Price by (ii) the number of shares of Fully-Diluted Cirronet Common Stock (the “Purchase Price”). Each Option
shall expire if such Option is not exercised prior to the close of business on the 180th day following termination of the Merger Agreement (“Option Expiration Date”). 
 (b) Parent may exercise any or all of the Options at any time (i) following the earlier of (A) the termination of the Merger Agreement and
(B) Cirronet’s first receipt of an Acquisition Proposal following the date hereof and (ii) until the Option Expiration Date. In the event that Parent wishes to exercise an Option, Parent shall give written notice (the date of such
notice being herein called the “Notice Date”), to Shareholder specifying a place and date (not later than ten Business Days and not earlier than three Business Days following the Notice Date) for closing such purchase (the
“Option Closing”). Parent agrees to exercise all Options granted by Shareholders pro rata according to the number of shares Cirronet Common Stock subject to each Option. 
 (c) If Parent shall exercise any Option in accordance with the terms of this Agreement, Shareholder shall execute and deliver further transfers,
assignments, endorsements, consents and other instruments as Parent may reasonably request for the purpose of effectively carrying out the transactions contemplated by this Agreement and the Merger Agreement, including the transfer of any and all of
Shareholder’s Shares Parent and the release of any and all liens, claims and encumbrances covering such Shares, without additional consideration. 
 (d) At the Option Closing, (i) Parent shall pay the aggregate Purchase Price for the Subject Shares being purchased from each Shareholder by wire transfer in immediately available funds of the total amount of the
Purchase Price for such Subject Shares to an account designated by Shareholder by written notice to Parent and (ii) Shareholder shall deliver to Parent a certificate or certificates evidencing the Subject Shares (provided that if any such
certificate is lost, then such Shareholder shall deliver a lost certificate affidavit and indemnity in customary form in lieu of such lost certificate), and Shareholder agrees that such Subject Shares shall be transferred free and clear of all
liens. All such certificates representing the Subject Shares shall be duly endorsed in blank, or with appropriate stock powers, duly executed in blank, attached thereto, in proper form for transfer, and with all applicable taxes paid or provided
for. 
 Section 5. Covenants of the Shareholder. The Shareholder hereby agrees and covenants that, during the period from the
date of this Agreement through the Option Expiration Date: 
 (a) Restriction on Transfers. Except as contemplated hereby or by the
Merger Agreement and as may otherwise be agreed to by Parent and Merger Subsidiary in writing, the Shareholder shall not (i) transfer (which term shall include, without limitation, any sale, gift, 
  

 4 

 pledge, hypothecation or other disposition), or consent to any transfer of, any or all of the Subject Shares, or any
interest therein if such transfer would result in the Shareholder no longer having the power to vote, or cause to be voted, the Subject Shares or (ii) enter into any contract, option or other agreement or understanding with respect to any such
transfer of any or all of the Subject Shares, or any interest therein; provided, however, that the Shareholder may (X) transfer Subject Shares to the Shareholder’s family members or a trust for any of their direct or indirect
benefit, (Y) transfer Subject Shares in a transaction involving the distribution without consideration of such Subject Shares to the Shareholder’s partners, members or shareholders, or the estate of any of them, and (Z) transfer
Subject Shares to any affiliate or subsidiary of the Shareholder; provided, further, that in each such case of (X), (Y) or (Z) above, each Person to which any of the Subject Shares are transferred shall have (v) executed
a counterpart of this Agreement and (w) agreed to hold such Subject Shares subject to the terms and provisions of this Agreement to the same extent as the Shareholder. 
 (b) Restrictions on Proxies and Voting Arrangements. Except as otherwise provided herein, the Shareholder shall not (i) grant any proxy,
power-of-attorney or other authorization in or with respect to the Subject Shares or (ii) deposit any of the Subject Shares into a voting trust or enter into a voting agreement or arrangement with respect to any of the Subject Shares.

 (c) Stop Transfer. The Shareholder shall not request that Cirronet register any transfer (book-entry or otherwise) of any
certificate or uncertificated interest representing any of the Shareholder’s Existing Securities, unless such transfer is made in compliance with this Agreement. 
 (d) Waiver of Appraisal Rights. The Shareholder hereby irrevocably and unconditionally waives, and agrees to prevent the exercise of, any rights of appraisal or rights to dissent in connection with the Merger
that the Shareholder may have with respect to the Subject Shares. 
 (e) No Solicitation. The Shareholder, solely in its capacity as a
shareholder of Cirronet, will not and will cause its affiliates, directors, officers, employees, agents and representatives not to, directly or indirectly, (i) solicit, initiate, facilitate or encourage the submission of any Acquisition
Proposal, (ii) enter into any agreement, arrangement or understanding with respect to any Acquisition Proposal, or (iii) explore or otherwise participate in any discussions or negotiations regarding, or furnish to any Person (other than
Parent and its Representatives) any information with respect to, or take any other action to facilitate any inquiries or the making of any proposal that constitutes, or leads to, an Acquisition Proposal. Notwithstanding the foregoing, if Cirronet
pursuant to Section 8.1(b) of the Merger Agreement is permitted to furnish information to and engage in discussions and negotiations with a third party, then the Shareholder may also furnish information to, and participate in discussions and
negotiations with, such third party to the same extent, but subject to the same limitations, as Cirronet as set forth in the Merger Agreement. 
 (f) No Inconsistent Arrangements. The Shareholder shall not take any other action that would in any material way restrict, limit or interfere with the performance of any of the Shareholder’s obligations hereunder or the
transactions contemplated hereby or by the Merger Agreement. 
  

 5 

 Section 6. Representations and Warranties. 
 (a) The Shareholder hereby represents and warrants to Parent and Merger Subsidiary as follows: 
 (i) Ownership of Securities. On the date hereof, the Shareholder beneficially owns, or has the sole power to direct the voting of, Cirronet Common
Stock set forth next to the Shareholder’s name on Schedule I hereto (the “Existing Securities”), free and clear of any voting or proxy restriction other than pursuant to this Agreement. On the date hereof, the Existing
Securities constitute all of the shares of voting capital stock of Cirronet beneficially owned by the Shareholder or as to which the Shareholder has the sole power to direct the voting of the shares. At the Option Closing Shareholder will deliver
good and valid title to the Subject Shares free and clear of any pledge, lien, security interest, charge, claim, equity, option, proxy, voting restrictions, right of first refusal or other limitation on disposition or encumbrance of any kind, other
than pursuant to this Agreement. Shareholder has full right, power and authority to sell, transfer and deliver the Subject Shares pursuant to this Agreement. Upon delivery of the Subject Shares and payment of the Purchase Price therefor as
contemplated herein, Parent will receive good and valid title to the Subject Shares, free and clear of any pledge, lien, security interest, charge, claim, equity, option, proxy, voting restriction or encumbrance of any kind. 
 (ii) Power; Binding Agreement. The Shareholder has the power (or, if applicable, entity power) and authority to enter into and perform all of the
Shareholder’s obligations hereunder, including, without limitation, the power and authority to (A) vote the Subject Shares in accordance with Section 2 hereof, (B) grant the proxy in accordance with Section 3 hereof and
(C) grant the Option in accordance with Section 4 hereof. The execution, delivery and performance of this Agreement by the Shareholder will not violate any other agreement to which the Shareholder is a party including, without limitation,
any voting agreement, proxy arrangement, pledge agreement, shareholders agreement, voting trust or trust agreement. This Agreement has been duly and validly executed and delivered by the Shareholder and constitutes a valid and binding agreement of
the Shareholder, enforceable against the Shareholder in accordance with its terms, except that (A) such enforcement may be subject to applicable bankruptcy, insolvency, moratorium, or other similar laws, now or hereafter in effect, affecting
creditors’ rights generally and (B) the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be
brought. There is no beneficiary or holder of a voting trust certificate or other interest of any trust of which the Shareholder is a trustee whose consent is required for the execution and delivery of this Agreement or the compliance by the
Shareholder with the terms hereof. 
 (iii) No Conflicts. None of the execution and delivery of this Agreement by the Shareholder, the
consummation by the Shareholder of the transactions contemplated hereby or compliance by the Shareholder with any of the provisions hereof shall (A) conflict with, or result in any breach of, any organizational documents applicable to the
Shareholder if the 

  

 6 

 
Shareholder is an entity, (B) result in a violation or breach of, or constitute (with or without due notice or lapse of time or both) a default (or give
rise to any third party right of termination, cancellation, material modification or acceleration) under any of the terms, conditions or provisions of any note, loan agreement, bond, mortgage, indenture, license, contract, commitment, arrangement,
understanding, agreement or other instrument or obligation of any kind to which the Shareholder is a party or by which the Shareholder or any of the Subject Shares may be bound, or (C) violate any order, writ, injunction, decree, judgment,
order, statute, arbitration award, rule or regulation applicable to the Shareholder or any of the Subject Shares, in each case, in a manner that could reasonably be expected to materially hinder or impede the Shareholder’s ability to perform
its obligations hereunder. 
 (iv) No Encumbrances. Except as established hereby, the Existing Securities are now and, at all times
during the term hereof, will be held by the Shareholder, or by a nominee or custodian for the benefit of the Shareholder, free and clear of all proxies, voting trusts, agreements, understandings or arrangements whatsoever, in each case, that could
reasonably be expected to materially hinder or impede the Shareholder’s ability to perform its obligations hereunder. 
 (v) Shareholder
has received and reviewed a copy of the Merger Agreement. 
 (vi) Shareholder is an “accredited investor” as defined in Rule 501 of
Regulation D promulgated under the Securities Act of 1933, as amended. 
 (b) Parent and Merger Subsidiary, jointly and severally, represent
and warrant to the Shareholder as follows: 
 (i) Power; Binding Agreement. Each of Parent and Merger Subsidiary has the corporate
power and authority to enter into and perform all of its obligations under this Agreement. This Agreement has been duly and validly executed and delivered by each of Parent and Merger Subsidiary and constitutes a valid and binding agreement of each
of Parent and Merger Subsidiary, enforceable against each of them in accordance with its terms, except as the enforceability thereof may be limited by (A) applicable bankruptcy, insolvency, moratorium, reorganization or similar laws in effect
that affect the enforcement of creditors rights generally or (B) general principles of equity, whether considered in a proceeding at law or in equity. 
 Section 7. Miscellaneous. 
 (a) Notices. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by telecopy, overnight delivery service from a national carrier or by registered or certified mail
(postage prepaid, return receipt requested) to the respective parties as follows: 
  

 7 

							
	if to Cirronet:
			
		 		 	Cirronet Inc.
		 		 	3079 Premiere Parkway, Suite 140
		 		 	Duluth, Georgia 30097
		 		 	Attention:	  	Robert M. Gemmell
		 		 	Telephone:	  	(678) 684-2008
		 		 	Telecopy:	  	(678) 684-2001
	
	with a copy to (which shall not constitute notice):
			
		 		 	Rogers & Hardin LLP
		 		 	2700 International Tower
		 		 	229 Peachtree Street, NE
		 		 	Atlanta, Georgia 30303
		 		 	Attention:	  	Alan C. Leet, Esq.
		 		 	Telephone:	  	(404) 522-4700
		 		 	Telecopy:	  	(404) 525-2224
	
	if to Parent or Merger Subsidiary:
			
		 		 	RF Monolithics, Inc.
		 		 	4441 Sigma Road
		 		 	Dallas, Texas 75244
		 		 	Attention:	  	David Kirk, President
		 		 	Telephone:	  	(972) 448-3732
		 		 	Telecopy:	  	(972) 404-9476
	
	with a copy to (which shall not constitute notice):
			
		 		 	Morton PLLC
		 		 	12222 Merit Drive, Suite 1270
		 		 	Dallas, Texas 75251
		 		 	Attention:	  	Steve Morton, Esq.
		 		 	Telephone:	  	(972) 490-6688
		 		 	Telecopy:	  	(972) 934-9299
	
	if to Shareholder:

 As listed on Schedule I hereto. 
 or to such other address as the Person to whom notice is given may have previously furnished to the others in writing in the manner set forth above. 
 (b) Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law, or
public policy, all other conditions and 
  

 8 

 provisions of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any term or
other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner
in order that the Merger be consummated as originally contemplated to the fullest extent possible. 
 (c) Entire Agreement. This
Agreement constitutes the entire agreement among the parties with respect to the subject matter hereof and supersedes all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter
hereof. 
 (d) Assignment. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and
their respective successors and assigns, provided that, except as provided herein, no party may assign, delegate or otherwise transfer any of its rights or obligations hereunder, in whole or in part, by operation of law or otherwise by any of the
parties, without the consent of the other parties hereto. 
 (e) Parties in Interest. This Agreement shall be binding upon and inure
solely to the benefit of each party hereto, and nothing herein, express or implied, is intended to or shall confer upon any other Person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement. 
 (f) Specific Performance. The parties hereto agree that irreparable damage would occur in the event any provision of this Agreement was not
performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or equity. 
 (g) Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware (regardless of the
laws that might otherwise govern under applicable principles of conflicts of law) as to all matters, including, but not limited to, matters of validity, construction, effect, performance and remedies. 
 (h) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR
COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF PARENT, ACQUISITION OR THE COMPANY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT THEREOF. 
 (i) Further Assurances. At the request of Parent or Merger Subsidiary the Shareholder shall execute and deliver to Parent and Merger Subsidiary,
or cause the record holder of Subject Shares to execute and deliver to Parent and Merger Subsidiary, such additional letters or instruments to comply with applicable Law and stock exchange rules as Parent or Merger Subsidiary may reasonably request
in connection with the Shareholder’s obligations under this Agreement and take such further acts and execute such further documents and instruments as may be necessary to vest in Parent the power to carry out the provisions of this Agreement.

  

 9 

 (j) Descriptive Headings; Interpretation. The descriptive headings herein are inserted for
convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Agreement. 
 (k)
Amendment, Modification and Waiver. This Agreement may not be amended, modified or waived except by an instrument or instruments in writing signed and delivered on behalf of the party hereto against whom such amendment, modification or waiver
is sought to be entered. 
 (l) Counterparts. This Agreement may be executed and delivered (including by facsimile transmission) in
one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed and delivered shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

 (m) No Limitation on Actions of Shareholder as Director. Notwithstanding anything to the contrary contained in this Agreement, in
the event that the Shareholder is a director of Cirronet, nothing in this Agreement is intended or shall be construed to require the Shareholder, in the Shareholder’s capacity as a director of Cirronet, to fail to act in accordance with the
Shareholder’s fiduciary duties in such capacity. 
 [Remainder of Page Intentionally Left Blank] 
  

 10 

 IN WITNESS WHEREOF, Parent, Merger Subsidiary, Cirronet and the Shareholders have caused this Agreement
to be duly executed as of the day and year first above written. 
  

			
	CIRRONET INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	RF MONOLITHICS, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CI ACQUISITION, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 11 

			
	SHAREHOLDERS:
	
	  

	(print name of shareholder above)
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	(if applicable)
	
	  

	(print name of shareholder above)
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	(if applicable)
	
	  

	(print name of shareholder above)
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	(if applicable)
	
	  

	(print name of shareholder above)
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	(if applicable)

 SCHEDULE I  
 LIST OF EXISTING SECURITIES 
  

					
	 Registered Holder
	 	 Number of Shares Held
	 	 Notice Information

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]